Health Insights You Can Count On

Sonic Incytes is redefining the standard of care in quantifying liver stiffness and attenuation.


Sonic Incytes

Our mission is to make liver health a new vital sign. Our first product, Velacur™️, aids in the clinical management of patients with liver disease, with measurements you can count on.


Handheld Solution

Our proprietary technology uses steady state waves, the same used by MRI elastography, to quantify liver stiffness, paving the way for a non-invasive, low-cost and scalable solution for physicians.

A Better Tool

for Physicians

We deliver real-time measurements of liver tissue stiffness and attenuation that can be used in conjunction with other clinical indicators to assess chronic liver disease.

Improving Patient Care


Patient Care

Designed with patients in mind, Velacur™️ is comfortable, quick and safe for a range of body types.



Sonic Incytes Recognized at 2023 LSBC Awards Gala

Sonic Incytes was recognized as a “Company to Watch” at the 25th Annual LSBC Awards Gala, presented by Farris. This


Sonic Incytes to Present Data at EASL International Liver Congress™️ 2023

Velacur™️ ACE Outperforms FibroScan®️ CAP for Liver Fat Quantification We are excited to announce that clinical data from Sonic Incytes’


Sonic Incytes Receives FDA 510(k) Clearance of AI Powered Features for Velacur™️ Liver Ultrasound

Sonic Incytes is pleased to announce they have received Food and Drug Administration (FDA) clearance for new Organ Guide and


Sonic Incytes Announces New Non-Dilutive Funding to Enhance Company’s Velacur™️ Medical Device

Sonic Incytes Medical Corp. is pleased to announce its project was selected for investment by the inaugural INOVAIT Focus Fund.

Interested in measuring liver stiffness and attenuation in your patients?

If you’d like to pave the way with us, let us know.

Sync up

with Sonic

Be in-the-know on all our latest news!

Subscribe to our newsletter.